Disease trajectories in interstitial lung diseases - data from the EXCITING-ILD registry.

"Declarations Ethics approval and consent to participateThe study was conducted ethically in accordance with the World Medical Association Declaration of Helsinki and was approved by the Ethics Committee of the Medical Faculty of the University of Heidelberg, Germany (S-525/2013) as well as by all local ethics committees of the participating centres. Informed consent to participate in the study was obtained from all participants. Consent for publicationNot applicable. Conflict of interestKB received payment for lectures from Boehringer Ingelheim and a grant from Sarkoidose-Netzwerk e.V. LH received fees for consulting and lectures from Boehringer-Ingelheim, GSK, AstraZeneca, Pfizer and BMS. PH received fees for lectures from Galapagos, GSK, Boehringer Ingelheim, AstraZeneca, Roche. DS reports fees for lectures or consultations from AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Janssen, MSD, Sanofi, all outside the submitted work. CS reports fees for lectures GSK, AstraZeneca, Boehringer Ingelheim, Berlin Chemie. MJ reports fees for lectures or consultations from AstraZeneca, Bencard, Boehringer Ingelheim, GSK, HAL Allergy, Sanofi, all outside the submitted work. SV reports fees from Berlin Chemie, GSK, Lilly, Pfizer, and Boehringer-Ingelheim. LS reports consulting fees from Galapagos. JB reports personal fees for lectures and consulting from Astra-Zeneca, Biogen, Boehringer-Ingelheim, BMS, Ferrer, Novartis, Roche, and Sanofi. AG reports grants, leture payments and/or consulting fees from Boehringer Ingelheim, Roche, Lung Therapeutics and Pieris. MP has received payment or honoraria for lectures, presentations or educational events from Boehringer Ingelheim and AstraZeneca. VS received support for attending meetings from CSL Behring. PM received fees for consulting and lectures from Boehringer-Ingelheim and Roche. MK reports grants, consulting fees, or payment for lectures from Boehringer Ingelheim, Galapagos, AstraZeneca, BMS and Roche. All other authors have nothing to disclose. The registry was supported by an unrestricted grant by Roche. Competing interestsThe authors declare no competing interests. Conflict of interest KB received payment for lectures from Boehringer Ingelheim and a grant from Sarkoidose-Netzwerk e.V. LH received fees for consulting and lectures from Boehringer-Ingelheim, GSK, AstraZeneca, Pfizer and BMS. PH received fees for lectures from Galapagos, GSK, Boehringer Ingelheim, AstraZeneca, Roche. DS reports fees for lectures or consultations from AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Janssen, MSD, Sanofi, all outside the submitted work. CS reports fees for lectures GSK, AstraZeneca, Boehringer Ingelheim, Berlin Chemie. MJ reports fees for lectures or consultations from AstraZeneca, Bencard, Boehringer Ingelheim, GSK, HAL Allergy, Sanofi, all outside the submitted work. SV reports fees from Berlin Chemie, GSK, Lilly, Pfizer, and Boehringer-Ingelheim. LS reports consulting fees from Galapagos. JB reports personal fees for lectures and consulting from Astra-Zeneca, Biogen, Boehringer-Ingelheim, BMS, Ferrer, Novartis, Roche, and Sanofi. AG reports grants, leture payments and/or consulting fees from Boehringer Ingelheim, Roche, Lung Therapeutics and Pieris. MP has received payment or honoraria for lectures, presentations or educational events from Boehringer Ingelheim and AstraZeneca. VS received support for attending meetings from CSL Behring. PM received fees for consulting and lectures from Boehringer-Ingelheim and Roche. MK reports grants, consulting fees, or payment for lectures from Boehringer Ingelheim, Galapagos, AstraZeneca, BMS and Roche. All other authors have nothing to disclose. The registry was supported by an unrestricted grant by Roche. Competing interests The authors declare no competing interests."

"Funding This study was supported by an unrestricted grant from InterMune (now Roche). Financial support is independent of the scientific concept of the registry, data analysis, interpretation, or publication other than an acknowledgement of financial support."